The Blackburn local government area had the highest incidence of tuberculosis in England and Wales in 1970,' the Because of the continuing high incidence of tuberculosis in the general population, and in children in particular, routine prophylactic chemotherapy was introduced in November 1981 throughout the district. Secondary chemo- Table 1 Notifications of cases of tuberculosis 1978-81 1978 1970 1980 198R The regimen chosen initially was isoniazid 10 mg/kg and rifampicin 10 mg/kg, with pyridoxine 10 mg daily for nine months. Rifampicin was included to reduce the length of treatment, and because of the high incidence (6%) locally of primary isoniazid resistance seen in the index cases from the Indian subcontinent.'2 The dosage of rifampicin (10 mg/kg) was chosen because this was at the lower end of the dose range of 10-20 mg/kg recommended for children, and older children of 30 kg and over would not receive a dose above the maximum recommended of 600 mg/day. Because of the high incidence of the disease in children in 1981 when the regimen was introduced, the duration of the initial course was deliberately made longer than we intended to use later (six months), to make as large an impact as possible on the incidence in children. Compliance was monitored by monthly visits from the health visitor who also checked with the chemists and general practitioners that regular prescriptions were being obtained. Children were seen every three months at the clinic during the course of treatment and had an x-ray picture taken before chemoprophylaxis was stopped. From November 1981 to December 1984 children were checked six and 15 months after drug treatment was stopped. From January 1985 children were discharged after completing the six months' course.
Methods
The case notes of all children notified as having tuberculosis between 1978 and 1980 were reviewed. These cases were true notifications with evidence of primary tuberculosis or mediastinal tuberculous lymphadenopathy on chest x-ray picture, or histological evidence of non-pulmonary tuberculosis. No child had been notified for chemoprophylaxis rather than treatment. There has been no change in the consultant staff in chest medicine or paediatrics since 1981, and they have maintained the same clinical criteria for the diagnosis of tuberculosis throughout.
Results Table 2 shows the number of children given chemoprophylaxis, the duration of treatment, and the ethnic distribution. Drug reactions were uncommon. Four children of 339 (1-2%) had their chemoprophylaxis changed to isoniazid 10 mg/kg and ethambutol 15 mg/kg because of vomiting. No case of rash, obvious liver function abnormality, or peripheral neuropathy was seen. Only two children of 339 (0-6%) who received chemoprophylaxis subsequently developed clinical tuberculosis (one each in 1985 and 1986) , and there were reservations about compliance in these cases. Four children whose parents refused to give them chemoprophylaxis when so advised developed clinical tuberculosis within 12 months of that advice. Table 3 shows notifications for 1978 to 1986. There are significant differences between the total Table 3 Notifications of children with tuberculosis 1978-1986 1978 1979 1980 1981 1982 1983 1984 1985 benefit not just over the period of treatment, but also in subsequent years. In addition, as the number of children whose skin tests were strongly positive to tuberculin decreased over the period 1982-86 it implies that most of the reservoir of those at highest risk of developing tuberculosis had been given prophylactic treatment, which again has a cumulative effect on the pattern of the disease. The data in the group from the Indian subcontinent do show this trend, with no significant differences for the first year after the prophylaxis had started, but having an increasingly significant effect (with the exception of 1985 when two of the six cases were found on entry to the United Kingdom, and were thus not preventable by prophylaxis). 
